Pharvaris N.V.
PHVS
$28.42
$4.3017.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.11% | 29.29% | 42.29% | 50.33% | 40.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.16% | 43.36% | 51.50% | 50.23% | 39.17% |
| Operating Income | -33.16% | -43.36% | -51.50% | -50.23% | -39.17% |
| Income Before Tax | -26.12% | -48.49% | -42.08% | -32.85% | -25.51% |
| Income Tax Expenses | 14.81% | 57.26% | 43.03% | 73.14% | 126.79% |
| Earnings from Continuing Operations | -26.01% | -48.59% | -42.09% | -33.27% | -26.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.01% | -48.59% | -42.09% | -33.27% | -26.08% |
| EBIT | -33.16% | -43.36% | -51.50% | -50.23% | -39.17% |
| EBITDA | -33.22% | -43.48% | -51.63% | -50.33% | -39.27% |
| EPS Basic | -14.73% | -30.34% | -12.58% | 5.06% | 12.87% |
| Normalized Basic EPS | -14.86% | -30.30% | -12.51% | 5.45% | 13.33% |
| EPS Diluted | -14.73% | -30.34% | -12.58% | 5.06% | 12.87% |
| Normalized Diluted EPS | -14.86% | -30.30% | -12.51% | 5.45% | 13.33% |
| Average Basic Shares Outstanding | 9.61% | 12.85% | 25.03% | 40.78% | 43.92% |
| Average Diluted Shares Outstanding | 9.61% | 12.85% | 25.03% | 40.78% | 43.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |